Author: TELOGENIS Editorial Board Review Status: Pending independent scientific review Updated: June 9, 2026 Evidence Grade: Editorial

Mission

TELOGENIS.org exists to bridge the gap between peer-reviewed longevity science and public understanding. We believe that evidence-based education is the foundation of informed decision-making about healthspan optimization.

Our mission is to curate, summarize, and contextualize research in telomere biology, cellular senescence, and aging mechanisms—making complex science accessible without sacrificing accuracy.

Vision

We envision a world where the public can distinguish between robust scientific evidence and commercial hyperbole in the longevity space. By establishing transparent editorial standards and independent scientific review, we aim to become a trusted reference point for researchers, clinicians, journalists, and curious individuals alike.

Scientific Philosophy

TELOGENIS.org adheres to the following core principles:

Independence Statement

TELOGENIS.org operates independently from TELOGENIS.com and any commercial entities. While the .com platform may engage in commercial activities, the .org domain is strictly educational and non-commercial. All editorial decisions are made by the Scientific Advisory Board without commercial input.

Transparency Policy

We maintain complete transparency regarding our operations:

Editorial Policy

Our editorial process follows a three-stage review:

  1. Draft Preparation: Written by a subject-matter researcher or science communicator with relevant training.
  2. Scientific Review: Independently reviewed by a member of the Scientific Advisory Board for factual accuracy, balance, and appropriate caveats.
  3. Editorial Review: Checked for clarity, accessibility, regulatory compliance, and internal consistency.

Articles are updated quarterly or when significant new evidence emerges. Outdated articles are clearly marked with revision notices.

Funding Disclosure

TELOGENIS.org is funded through a combination of:

We do not accept funding from supplement manufacturers, pharmaceutical companies, or any entity with a direct commercial interest in the interventions discussed on this platform. A complete list of funders is available upon request.

Research Standards

All research summaries on TELOGENIS.org must meet the following minimum criteria:

We do not summarize preprints, conference abstracts, or industry white papers as primary evidence.

Scientific Review Process

Each article is assigned a reviewer based on subject-matter expertise. Reviewers evaluate:

Reviewers have the authority to reject or request revision of any content that does not meet these standards.